Comments

Range Cancer Therapeutics ETF

CNCRNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$15.35
-0.0023-0.01%
Last update: 10:54 AM
15 minutes delayed
OverviewNews

Holdings

DividendsShort Interest
Number of Stock Holdings
86
Number of Bond Holdings
-
Total Holdings
87
Number of ETFs
-

Range Cancer Therapeutics ETF (NASDAQ:CNCR), Top Holdings

Range Cancer Therapeutics ETF (NASDAQ: CNCR)

TickerNameShare %
JANXJanux Therapeutics Inc.4.17%
MGNXMacrogenics Inc3.27%
MRSNMersana Therapeutics Inc3.26%
YMABY-Mabs Therapeutics Inc Com2.85%
FATEFate Therapeutics Inc2.74%
IOVAIovance Biotherapeutics Inc2.57%
AMAMAmbrx Inc2.54%
IBRXImmunitybio Inc.2.24%
SMMTSummit Therapeutics Plc Spon Adr2.07%
RVMDRevolution Medicines Inc2.02%

FAQ

Q

How has CNCR ETF performed?

A

The CNCR ETF is currently trading at $15.35, which represents a -0.01% change. Over the past 52 weeks, the ETF has traded as high as $17.96 and as low as $9.22.

Q

What is the expense ratio for CNCR?

A

The expense ratio of CNCR is 0.79%. This represents the annual fee that all funds or ETFs charge their shareholders.

Q

What is the Assets Under Management (AUM) for CNCR?

A

The total Assets Under Management (AUM) for CNCR is 13.98M. This represents the total market value of the assets managed by the ETF.

Q

What is the investment style for CNCR?

A

CNCR follows a Small Cap Blend investment style.

Q

What are the top holdings for CNCR?

A

The top holdings of CNCR include: JANX (4.17%), MGNX (3.27%), MRSN (3.26%), YMAB (2.85%), FATE (2.74%). These represent the largest positions in the ETF's portfolio.

Q

What is the average daily trading volume for CNCR?

A

Average daily volume data for CNCR is currently not available.